Skip to main content
. 2020 May 27;73(3):450–459. doi: 10.1093/cid/ciaa646

Table 3.

ELF Index Performance for Identification of Liver Fibrosis/Cirrhosis in HIV/HCV Versus HCV Patients

HIV/HCV HCV
ELF Index Cutoff Sensitivity (%) Specificity (%) PPV (%) NPV (%) ELF Index Cutoff Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Any/mild fibrosis ≥F1 7.42 100 12 85 100 7.91 100 11 83 100
7.86 98 24 86 67 8.3 99 39 88 88
8.45 85 60 91 46 8.72 85 67 92 50
8.52 81 68 93 43 8.85 81 89 97 52
8.85 68 84 95 35 8.91 76 89 97 46
8.89 66 88 96 34 9.05 67 100 100 41
9.09 56 100 100 32
Advanced fibrosis ≥F3 9.48 97 89 74 99 9.49 100 90 81 100
9.62 89 96 86 96 9.62 97 94 88 98
9.81 71 98 93 92 9.8 73 99 96 89
Cirrhosis F4 9.49 100 79 37 100 9.69 100 82 48 100
9.81 81 89 48 98 9.8 93 88 57 99
10.18 69 98 79 96 10.17 71 98 83 95
10.45 63 99 80 94 10.41 64 99 90 94
11.34 38 100 100 93 11.14 7 100 100 87

Abbreviations: ELF, enhanced liver fibrosis; HCV, hepatitis C virus; HIV, human immunodeficiency virus; NPV: negative predictive value; PPV, positive predictive value.